Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Hisashi Saji(St. Marianna University School of Medicine), Hisao Asamura(Keio University), Kenji Suzuki(Juntendo University), Shun‐ichi Watanabe(Tokyo National Hospital), Keiju Aokage(National Cancer Center Hospital East), Haruhiko Fukuda(National Cancer Center Hospital East), Hiroyuki Ito(Kanagawa Prefectural Hospital Organization), Masahiro Tsuboi(National Cancer Center Hospital East), Masashi Wakabayashi(Japan Clinical Cancer Research Organization), Jiro Okami(Osaka Medical Center for Cancer and Cardiovascular Diseases), Tetsuya Mitsudomi(Kindai University), Norihito Okumura(Kurashiki Central Hospital), Kenichi Nakamura(Japan Clinical Cancer Research Organization), Shinichiro Nakamura(Japan Clinical Cancer Research Organization), Norihiko Ikeda(Tokyo Medical University), Morihito Okada(Hiroshima University), Ichiro Yoshino(International University of Health and Welfare), Masafumi Yamaguchi(National Hospital Organization Kyushu Cancer Center), Ryu Nakajima(Osaka City General Hospital), Tadashi Aoki(Niigata Cancer Center Hospital)
Cited by 1,638
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
|Cancer Research|2004|2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k